Steroid-Free Remission in Patients With Ulcerative Colitis Receiving Tofacitinib in Real Clinical Practice

被引:0
|
作者
Oleg, Knyazev [1 ]
Anna, Kagramanova [1 ]
Albina, Lishchinskaya [1 ]
Anait, Babayan [1 ]
Dmitriy, Kulakov [1 ]
Irina, Li [1 ]
Tatyana, Shkurko [2 ]
机构
[1] Moscow Clin Sci Ctr, Moscow, Russia
[2] Res Inst Hlth Org & Med Management, Moscow, Russia
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P004
引用
收藏
页码:S1 / S1
页数:1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Upadacitinib and Tofacitinib in Inducing Remission in Ulcerative Colitis: Real-World Data
    Boneschansker, Leo
    Ananthakrishnan, Ashwin N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2427 - +
  • [43] Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Hart, Ailsa
    Alharbi, Othman R.
    Salese, Leonardo
    Lawendy, Nervin
    Mundayat, Rajiv
    Su, Chinyu
    Reinisch, Walter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S323 - S323
  • [44] DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAIVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS
    Liu, Xiaoxuan
    Reigle, James
    Sharma, Mihika
    Lopez-Nunez, Oscar
    Walters, Thomas D.
    Collins, Margaret H.
    Hyams, Jeffrey S.
    Siddiqui, Iram
    Denson, Lee A.
    Jegga, Anil
    Prasath, Surya
    Dhaliwal, Jasbir
    GASTROENTEROLOGY, 2023, 164 (06) : S170 - S171
  • [45] DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAIVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS
    Dhaliwal, Jasbir
    Liu, Xiaoxuan
    Reigle, Jim
    Sharma, Mihika
    Lopez-Nunez, Oscar
    Walters, Tom
    Collins, Margaret
    Hyams, Jeffrey
    Siddiqui, Iram
    Denson, Lee
    Jegga, Anil
    Prasath, Surya
    GASTROENTEROLOGY, 2023, 164 (04) : S72 - S73
  • [47] Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice
    Kotze, Paulo G.
    Teixeira, Fabio V.
    Damiao, Aderson O. M. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1208 - 1209
  • [48] Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
    Rubin, D. T.
    Travis, S.
    Abraham, B. P.
    Su, C.
    Lawendy, N.
    Fan, H.
    Woodworth, A.
    Thorpe, A. J.
    Nduaka, C. I.
    Quirk, D.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S425 - S426
  • [49] MAINTENANCE OF EFFICACY FOLLOWING TOFACITINIB DOSE REDUCTION IN PATIENTS WITH ULCERATIVE COLITIS IN STABLE REMISSION
    Rubin, David T.
    Travis, Simon P.
    Abraham, Bincy P.
    Su, Chinyu
    Lawendy, Nervin
    Fan, Haiyun
    Woodworth, Deborah A.
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Quirk, Daniel
    Reinisch, Walter
    GASTROENTEROLOGY, 2019, 156 (06) : S1098 - S1098
  • [50] Sustained steroid-free clinical remission in patients with moderate to severe Crohn's disease treated with adalimumab
    Hanauer, Stephen B.
    Kaam, M. A.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S460 - S460